Question Title

* 1. Lucas is a 38-year-old man diagnosed with moderate-to-severe UC after being referred to a gastroenterologist for symptoms that began over a year ago. After having participated in this program, which of the following is most consistent with how you would approach minimizing his risk for irreversible bowel damage?

Question Title

* 2. How many years have you been in practice?

Question Title

* 3. How many patients with IBD do you manage per month?  

Question Title

* 4. Please select the option that best describes your practice setting.  

Question Title

* 5. After participating in this activity, how confident are you in the management of patients with IBD in your practice? 

Question Title

* 6. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 7. Which of the following best describes the impact of this activity on your performance?

Question Title

* 8. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 9. What barriers do you see to making changes in your practice? Please select all that apply.  

Question Title

* 10. Please rate your level of agreement by checking the appropriate rating.

 After participating in today’s activity, I am now better able to:

  Strongly agree Agree Neutral Disagree Strongly disagree
Recognize the prevalence of suboptimal outcomes in IBD and understand the value of routine disease monitoring for successful management
Evaluate the benefits associated with the earlier introduction of new targeted therapies into the management of UC
Apply clinical data to clinical practice and incorporate new and emerging IBD therapies, once they become available, to improve patient outcomes
Develop an evidence-based treatment selection protocol and incorporate patient preferences into shared decision-making for the successful management of IBD

Question Title

* 11. Please rate your level of agreement by checking the appropriate rating.

Marla C. Dubinsky, MD effectively:

  Strongly agree Agree Neutral Disagree Strongly disagree
Presented the Material
Avoided Commercial Bias

Question Title

* 12. Please rate your level of agreement by checking the appropriate rating.

Edward V. Loftus, Jr., MD effectively:

  Strongly agree Agree Neutral Disagree Strongly disagree
Presented the Material
Avoided Commercial Bias

Question Title

* 13. Please rate your level of agreement by checking the appropriate rating.

The content presented:

  Strongly agree Agree Neutral Disagree Strongly disagree
Enhanced my current knowledge base
Addressed my most pressing questions
Promoted improvements or quality in health care
Was scientifically rigorous and evidence based
Avoided commercial bias or influence

Question Title

* 14. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 15. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 16. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for IBD:

T